Related Experiment Video
Updated: May 14, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Effectiveness of standardized combination therapy for migraine treatment in the pediatric emergency department
Stephanie Leung1, Blake Bulloch, Christine Young
1Phoenix Children's Hospital, Phoenix, AZ 85016, USA.
Insights
Standardized intravenous therapy significantly reduced pain and emergency department (ED) stays for pediatric migraine patients. This approach improved outcomes compared to non-standardized treatments, lowering hospital admission rates.
Area of Science:
- Pediatric Emergency Medicine
- Neurology
- Clinical Therapeutics
Background:
- Migraine headaches account for a significant portion of pediatric emergency department visits (8-18%).
- Current acute pediatric migraine treatment lacks standardization, leading to variable patient outcomes.
Purpose of the Study:
- To evaluate the effectiveness of a standardized intravenous combination therapy for acute pediatric migraine.
- To compare treatment outcomes before and after implementing a consistent therapeutic regimen in a pediatric emergency department.
Main Methods:
- Retrospective chart review of pediatric migraine patients treated between August 2006 and March 2010.
- Comparison of outcomes between patients receiving non-standardized therapy and those treated with a standardized regimen (normal saline, ketorolac, prochlorperazine, diphenhydramine).
- Primary outcome: reduction in headache pain score; secondary outcomes: ED length of stay, hospital admission, and 48-hour readmission rates.
Main Results:
- Standardized therapy (87 patients) showed significant reductions in headache pain scores compared to non-standardized therapy (165 patients) (decrease of 6.9 vs. 5.3).
- Patients receiving standardized treatment experienced shorter emergency department stays (4.4 vs. 5.3 hours).
- Hospital admission rates were significantly lower in the standardized therapy group (3% vs. 32%).
Conclusions:
- A standardized intravenous combination therapy is effective for managing acute pediatric migraines in the emergency department.
- This standardized approach significantly improves pain management, reduces healthcare resource utilization (ED stay, hospital admission), and enhances patient care.
Objective:
To compare outcomes of pediatric migraine patients treated in an emergency department (ED) before and after implementation of a standardized combination intravenous therapy regimen aimed toward improving and standardizing abortive migraine therapy.
Background:
In a pediatric ED, migraines represent 8-18% of all headache visits. Despite this large number, no standard treatment for acute migraine therapy currently exists.
Methods:
The study utilized a retrospective chart review of patients seeking acute migraine treatment at a tertiary care, pediatric ED from August 2006 to March 2010. Inclusion criteria were pediatric migraine patients as defined by International Headache Society guidelines. The comparison population received various migraine therapies based on attending practice preference. After October 2008, patients received standardized intravenous combination therapy involving a normal saline fluid bolus, ketorolac, prochlorperazine, and diphenhydramine. Occasionally, metoclopramide was substituted during prochlorperazine shortages. Reduction in headache pain score was the primary outcome. Secondary outcome measures included length of ED stay, hospital admission rate, and ED readmission rate within 48 hours.
Results:
The study yielded 87 patients who received standardized combination therapy and 165 comparison patients. No significant difference in patient characteristics existed when evaluating patient demographics, outpatient medication use, and initial headache pain score. When compared with the non-standardized therapy population, the combination therapy patients revealed significant reductions in pain score (decrease of 5.3 vs. 6.9, difference -1.6, 95% confidence interval -2.2 to -0.8, P < .001), length of ED stay (5.3 vs. 4.4 hours, difference 0.9, 95% confidence interval 0.2-1.6, P = .008), and hospital admission rate (32% vs. 3%, P < .001) without changes in ED return rate (7% vs. 2%, P = .148).
Conclusion:
Standardized combination therapy is effective for acute pediatric migraine therapy in the ED by significantly reducing headache pain scores, length of ED stay, and hospital admission rates.
Related Concept Videos
Drug Delivery: Enteral Route
Drugs in...
Electroconvulsive Therapy